Keenan A Walker1, Jeremy Walston2, Rebecca F Gottesman1,3, Anna Kucharska-Newton4, Priya Palta4, B Gwen Windham5. 1. Department of Neurology, Center on Aging and Health, Baltimore, MD. 2. Division of Geriatric Medicine and Gerontology, Center on Aging and Health, Baltimore, MD. 3. Department of Epidemiology, Johns Hopkins University, Baltimore, MD. 4. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill. 5. Department of Medicine, Division of Geriatrics, University of Mississippi Medical Center, Jackson.
Abstract
BACKGROUND: Evidence suggests that systemic inflammation may have a mechanistic role in age-related frailty, yet prospective data is limited. We examined whether systemic inflammation during midlife was associated with late-life frailty within the community-based Atherosclerosis Risk in Communities Study. METHODS: Plasma levels of four inflammatory markers (fibrinogen, von Willebrand factor, and Factor VIII, and white blood cell count) were measured during Visit 1 (1987-1989; mean age: 52 [5]), standardized into z-scores, and combined to create an inflammation composite score. High-sensitivity C-reactive protein (CRP) was measured 3 (Visit 2, 1990-1992) and 9 (Visit 4, 1996-1999) years later. Frailty was evaluated in 5,760 participants during late life (Visit 5, 2011-2013; mean age: 75 [5]). Analyses were adjusted for demographic and physiological variables, and midlife medical comorbidity using logistic regression. RESULTS: A 1 SD increase in midlife inflammation composite score was associated with higher odds of frailty 24 years later (odds ratio [OR] = 1.39, 95% confidence interval [CI]: 1.18-1.65). Similarly, each standard deviation increase in Visit 2 CRP (OR = 1.24, 95% CI: 1.09-1.40) and Visit 4 CRP (OR = 1.35, 95% CI: 1.19-1.53) was associated with a higher odds of frailty 21 and 15 years later. Participants who maintained elevated CRP (≥3 mg/L) at Visits 2 and 4 or transitioned to a state of elevated CRP during this period were more likely to subsequently meet frailty criteria compared to those who maintained low CRP. These associations were stronger among white, compared to African American, participants (p-interactions < .038). CONCLUSIONS: Systemic inflammation during midlife may independently promote pathophysiological changes underlying frailty in a subset of the population.
BACKGROUND: Evidence suggests that systemic inflammation may have a mechanistic role in age-related frailty, yet prospective data is limited. We examined whether systemic inflammation during midlife was associated with late-life frailty within the community-based Atherosclerosis Risk in Communities Study. METHODS: Plasma levels of four inflammatory markers (fibrinogen, von Willebrand factor, and Factor VIII, and white blood cell count) were measured during Visit 1 (1987-1989; mean age: 52 [5]), standardized into z-scores, and combined to create an inflammation composite score. High-sensitivity C-reactive protein (CRP) was measured 3 (Visit 2, 1990-1992) and 9 (Visit 4, 1996-1999) years later. Frailty was evaluated in 5,760 participants during late life (Visit 5, 2011-2013; mean age: 75 [5]). Analyses were adjusted for demographic and physiological variables, and midlife medical comorbidity using logistic regression. RESULTS: A 1 SD increase in midlife inflammation composite score was associated with higher odds of frailty 24 years later (odds ratio [OR] = 1.39, 95% confidence interval [CI]: 1.18-1.65). Similarly, each standard deviation increase in Visit 2 CRP (OR = 1.24, 95% CI: 1.09-1.40) and Visit 4 CRP (OR = 1.35, 95% CI: 1.19-1.53) was associated with a higher odds of frailty 21 and 15 years later. Participants who maintained elevated CRP (≥3 mg/L) at Visits 2 and 4 or transitioned to a state of elevated CRP during this period were more likely to subsequently meet frailty criteria compared to those who maintained low CRP. These associations were stronger among white, compared to African American, participants (p-interactions < .038). CONCLUSIONS:Systemic inflammation during midlife may independently promote pathophysiological changes underlying frailty in a subset of the population.
Authors: Ming Xu; Tamara Tchkonia; Husheng Ding; Mikolaj Ogrodnik; Ellen R Lubbers; Tamar Pirtskhalava; Thomas A White; Kurt O Johnson; Michael B Stout; Vojtech Mezera; Nino Giorgadze; Michael D Jensen; Nathan K LeBrasseur; James L Kirkland Journal: Proc Natl Acad Sci U S A Date: 2015-11-02 Impact factor: 11.205
Authors: Anna M Kucharska-Newton; Priya Palta; Sheila Burgard; Michael E Griswold; Jennifer L Lund; Benjamin D Capistrant; Stephen B Kritchevsky; Karen Bandeen-Roche; B Gwen Windham Journal: J Gerontol A Biol Sci Med Sci Date: 2017-03-01 Impact factor: 6.053
Authors: Christina M Parrinello; Morgan E Grams; David Couper; Christie M Ballantyne; Ron C Hoogeveen; John H Eckfeldt; Elizabeth Selvin; Josef Coresh Journal: Clin Chem Date: 2015-05-07 Impact factor: 8.327
Authors: Charles X Kim; Kent R Bailey; George G Klee; Allison A Ellington; Guanghui Liu; Thomas H Mosley; Hamid Rehman; Iftikhar J Kullo Journal: PLoS One Date: 2010-02-05 Impact factor: 3.240
Authors: Krisztina Mekli; James Y Nazroo; Alan D Marshall; Meena Kumari; Neil Pendleton Journal: Aging Clin Exp Res Date: 2015-08-07 Impact factor: 3.636
Authors: Natalia Sonsin-Diaz; Rebecca F Gottesman; Elizabeth Fracica; Jeremy Walston; B Gwen Windham; David S Knopman; Keenan A Walker Journal: Am J Geriatr Psychiatry Date: 2019-05-21 Impact factor: 4.105
Authors: Lina Ma; Lolita S Nidadavolu; Huanle Yang; Jackie Langdon; Reyhan Westbrook; Benjamin M W Tsui; Taek-Soo Lee; Jared Hinson; Shizhang Ling; Ruth Marx-Rattner; Yuqiong Wu; Tu Nguyen; Jessica Tan; Mohammed Khadeer; Ruin Moaddel; Anne Le; Jeremy D Walston; Peter M Abadir Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-18 Impact factor: 6.053
Authors: Aida Venado; Charles McCulloch; John R Greenland; Patricia Katz; Allison Soong; Pavan Shrestha; Steven Hays; Jeffrey Golden; Rupal Shah; Lorriana E Leard; Mary Ellen Kleinhenz; Jasleen Kukreja; Lydia Zablotska; Isabel E Allen; Kenneth Covinsky; Paul Blanc; Jonathan P Singer Journal: J Heart Lung Transplant Date: 2019-03-18 Impact factor: 10.247
Authors: Keenan A Walker; Rebecca F Gottesman; Aozhou Wu; David S Knopman; Alden L Gross; Thomas H Mosley; Elizabeth Selvin; B Gwen Windham Journal: Neurology Date: 2019-02-13 Impact factor: 9.910
Authors: Heather M Derry; Carrie D Johnston; Chelsie O Burchett; Mark Brennan-Ing; Stephen Karpiak; Yuan-Shan Zhu; Eugenia L Siegler; Marshall J Glesby Journal: J Gerontol B Psychol Sci Soc Sci Date: 2022-01-12 Impact factor: 4.077